The GIP receptor activates futile calcium cycling in white adipose tissue to increase energy expenditure and drive weight loss in mice
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Summary Obesity is a chronic disease that contributes to the development of insulin resistance, type 2 diabetes (T2D), and cardiovascular risk. GIP receptor (GIPR) and GLP-1 receptor (GLP-1R) co-agonism provide an improved therapeutic profile in individuals with T2D and obesity when compared with selective GLP-1R agonism. While the metabolic benefits of GLP-1R agonism are established, whether GIPR activation impacts weight loss through peripheral mechanisms is yet to be fully defined. Here, we generated a mouse model of GIPR induction exclusively in the adipocyte. We show that GIPR induction in the fat cell protects mice from diet-induced obesity and triggers profound weight loss (~35%) in an obese setting. Adipose GIPR further increases lipid oxidation, thermogenesis and energy expenditure. Mechanistically, we demonstrate that GIPR induction activates SERCA-mediated futile calcium cycling in the adipocyte. GIPR activation further triggers a metabolic memory effect, which maintains weight loss after the transgene has been switched off, highlighting a unique aspect in adipocyte biology. Collectively, we present a mechanism of peripheral GIPR action in adipose tissue, which exerts beneficial metabolic effects on body weight and energy balance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9
Doench, J. G., Fusi, N., Sullender, M., Hegde, M., Vaimberg, E. W., Donovan, K. F., Smith, I., Tothova, Z., Wilen, C., Orchard, R., et al. (2016) · Nature Biotechnology · doi:10.1038/nbt.3437 · Cited by 4,637 · cited 1×
“A negative control guide (g) (g1, 5’-CTTCATACTGCACCGGGCGGG-3’) and two distinct Serca2 (Atp2a2) guides (g1, 5’-CATCGATAGGTGCACCCACAT-3’; g2, 5’-CCTCGTATTTGATGAAGTTAG-3’) were selected using CRISPick, 88,89 then cloned into a custom pAAVK mADIPOQP-SaCas9+U6-sgRNA vector.”
Tirzepatide Once Weekly for the Treatment of Obesity
Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., Kiyosue, A., Zhang, S., Liu, B., Bunck, M. C., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2206038 · Cited by 3,838
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
Pi-Sunyer, X., Astrup, A., Fujioka, K., Greenway, F., Halpern, A., Krempf, M., Lau, D. C. W., le Roux, C. W., Violante Ortiz, R., Jensen, C. B., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1411892 · Cited by 2,724
Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1
Drucker, D. J. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.03.001 · Cited by 2,170 · cited 1×
“10,37 We therefore examined (1) the relationship between systemic GLP-1R agonism versus adipocyte GIPR activation and (2) whether induction of GIPR in the fat cell further enhances the weight-loss efficacy of GLP-1R agonism.”
Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes
Frías, J. P., Davies, M. J., Rosenstock, J., Pérez Manghi, F. C., Fernández Landó, L., Bergman, B. K., Liu, B., Cui, X., & Brown, K. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2107519 · Cited by 2,096
Long-term weight loss maintenance
Wing, R. R., & Phelan, S. (2005) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/82.1.222s · Cited by 1,941 · cited 1×
“81 In fact, after significant weight loss, an immediate rebound in body weight is observed following withdrawal of GLP-1R agonist treatment, 82 with the degree of weight reduction exceeding placebo controls.”
Adipose tissue remodeling and obesity
Sun, K., Kusminski, C. M., & Scherer, P. E. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45887 · Cited by 1,941
Self-citationGlucagon-like peptide 1 (GLP-1)
Müller, T. D., Finan, B., Bloom, S. R., D'Alessio, D., Drucker, D. J., Flatt, P. R., Fritsche, A., Gribble, F., Grill, H. J., Habener, J. F., et al. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.09.010 · Cited by 1,868
Long-term weight-loss maintenance: a meta-analysis of US studies
Anderson, J. W., Konz, E. C., Frederich, R. C., & Wood, C. L. (2001) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/74.5.579 · Cited by 1,351
Research works printed but not linked: 50
- Abdelaal, 2017, Morbidity and mortality associated with obesity, Ann. Transl. Med., 5, 161, 10.21037/atm.2017.03.107 · DOI · Paper page
- Rudovich, 2007, GIP receptor mRNA expression in different fat tissue depots in postmenopausal non-diabetic women, Regul. Pept., 142, 138, 10.1016/j.regpep.2007.02.006 · DOI
- Beaudry, 2019, Physiological roles of the GIP receptor in murine brown adipose tissue, Mol. Metab., 28, 14, 10.1016/j.molmet.2019.08.006 · DOI · Paper page
- Campbell, 2022, GIPR Is Predominantly Localized to Nonadipocyte Cell Types Within White Adipose Tissue, Diabetes, 71, 1115, 10.2337/db21-1166 · DOI · Paper page
- Regmi, 2024, Tirzepatide modulates the regulation of adipocyte nutrient metabolism through long-acting activation of the GIP receptor, Cell Metab, 36, 1534, 10.1016/j.cmet.2024.05.010 · DOI · Paper page
- Widenmaier, 2010, A GIP receptor agonist exhibits beta-cell anti-apoptotic actions in rat models of diabetes resulting in improved beta-cell function and glycemic control, PLoS One, 5, 10.1371/journal.pone.0009590 · DOI · Paper page
- NamKoong, 2017, Central administration of GLP-1 and GIP decreases feeding in mice, Biochem. Biophys. Res. Commun., 490, 247, 10.1016/j.bbrc.2017.06.031 · DOI · Paper page
- Nørregaard, 2018, A novel GIP analogue, ZP4165, enhances glucagon-like peptide-1-induced body weight loss and improves glycaemic control in rodents, Diabetes Obes. Metab., 20, 60, 10.1111/dom.13034 · DOI · Paper page
- Kim, 2011, Adipocyte expression of the glucose-dependent insulinotropic polypeptide receptor involves gene regulation by PPARgamma and histone acetylation, J. Lipid Res., 52, 759, 10.1194/jlr.M012203 · DOI · Paper page
- Tharp, 2020, Effects of Pioglitazone on Glucose-Dependent Insulinotropic Polypeptide-Mediated Insulin Secretion and Adipocyte Receptor Expression in Patients With Type 2 Diabetes, Diabetes, 69, 146, 10.2337/db18-1163 · DOI
- Kusminski, 2020, A Novel Model of Diabetic Complications: Adipocyte Mitochondrial Dysfunction Triggers Massive beta-Cell Hyperplasia, Diabetes, 69, 313, 10.2337/db19-0327 · DOI · Paper page
- Considine, 1996, Serum immunoreactive-leptin concentrations in normal-weight and obese humans, N. Engl. J. Med., 334, 292, 10.1056/NEJM199602013340503 · DOI · Paper page
- Vidal-Puig, 1997, Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids, J. Clin. Invest., 99, 2416, 10.1172/JCI119424 · DOI · Paper page
- Miyazaki, 2001, Effect of rosiglitazone on glucose and non-esterified fatty acid metabolism in Type II diabetic patients, Diabetologia, 44, 2210, 10.1007/s001250100031 · DOI · Paper page
- Viswanathan, 2015, High-performance probes for light and electron microscopy, Nat. Methods, 12, 568, 10.1038/nmeth.3365 · DOI · Paper page
- Huang, 2017, Targeting Visceral Fat by Intraperitoneal Delivery of Novel AAV Serotype Vector Restricting Off-Target Transduction in Liver, Mol. Ther. Methods Clin. Dev., 6, 68, 10.1016/j.omtm.2017.06.002 · DOI · Paper page
- Zufferey, 1999, Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors, J. Virol., 73, 2886, 10.1128/JVI.73.4.2886-2892.1999 · DOI · Paper page
- Sohn, 2013, Neuronal circuits that regulate feeding behavior and metabolism, Trends Neurosci., 36, 504, 10.1016/j.tins.2013.05.003 · DOI · Paper page
- Samms, 2022, GIPR Agonism Inhibits PYY-Induced Nausea-Like Behavior, Diabetes, 71, 1410, 10.2337/db21-0848 · DOI · Paper page
- Ahima, 2000, Leptin, Annu. Rev. Physiol., 62, 413, 10.1146/annurev.physiol.62.1.413 · DOI · Paper page
- Zhao, 2019, Partial Leptin Reduction as an Insulin Sensitization and Weight Loss Strategy, Cell Metab., 30, 706, 10.1016/j.cmet.2019.08.005 · DOI · Paper page
- Zhao, 2020, Partial leptin deficiency confers resistance to diet-induced obesity in mice, Mol. Metab., 37, 10.1016/j.molmet.2020.100995 · DOI
- Asmar, 2016, Insulin Plays a Permissive Role for the Vasoactive Effect of GIP Regulating Adipose Tissue Metabolism in Humans, J. Clin. Endocrinol. Metab., 101, 3155, 10.1210/jc.2016-1933 · DOI · Paper page
- Pirro, 2022, Effects of Tirzepatide, a Dual GIP and GLP-1 RA, on Lipid and Metabolite Profiles in Subjects With Type 2 Diabetes, J. Clin. Endocrinol. Metab., 107, 363, 10.1210/clinem/dgab722 · DOI · Paper page
- Permyakov, 2020, Mouse S100G protein exhibits properties characteristic of a calcium sensor, Cell Calcium, 87, 10.1016/j.ceca.2020.102185 · DOI
- Jia, 2020, Synaptotagmin-4 promotes dendrite extension and melanogenesis in alpaca melanocytes by regulating Ca(2+) influx via TRPM1 channels, Cell Biochem. Funct., 38, 275, 10.1002/cbf.3465 · DOI
- Gonzalez, 2020, Role of S100 proteins in health and disease, Biochim. Biophys. Acta Mol. Cell Res., 1867, 10.1016/j.bbamcr.2020.118677 · DOI · Paper page
- Ikeda, 2017, UCP1-independent signaling involving SERCA2b-mediated calcium cycling regulates beige fat thermogenesis and systemic glucose homeostasis, Nat. Med., 23, 1454, 10.1038/nm.4429 · DOI · Paper page
- Seale, 2011, Prdm16 determines the thermogenic program of subcutaneous white adipose tissue in mice, J. Clin. Invest., 121, 96, 10.1172/JCI44271 · DOI · Paper page
- Vandecaetsbeek, 2011, The Ca2+ pumps of the endoplasmic reticulum and Golgi apparatus, Cold Spring Harb. Perspect. Biol., 3, 10.1101/cshperspect.a004184 · DOI · Paper page
- Guarnieri, 2022, Calcium cycling as a mediator of thermogenic metabolism in adipose tissue, Mol. Pharmacol., 102, 51, 10.1124/molpharm.121.000465 · DOI
- de Meis, 2003, Brown adipose tissue Ca2+-ATPase: uncoupled ATP hydrolysis and thermogenic activity, J. Biol. Chem., 278, 41856, 10.1074/jbc.M308280200 · DOI
- Kranias, 2012, Modulation of cardiac contractility by the phospholamban/SERCA2a regulatome, Circ. Res., 110, 1646, 10.1161/CIRCRESAHA.111.259754 · DOI · Paper page
- Sahoo, 2013, Sarcolipin protein interaction with sarco(endo)plasmic reticulum Ca2+ ATPase (SERCA) is distinct from phospholamban protein, and only sarcolipin can promote uncoupling of the SERCA pump, J. Biol. Chem., 288, 6881, 10.1074/jbc.M112.436915 · DOI · Paper page
- Bal, 2012, Sarcolipin is a newly identified regulator of muscle-based thermogenesis in mammals, Nat. Med., 18, 1575, 10.1038/nm.2897 · DOI · Paper page
- Autry, 2016, Sarcolipin Promotes Uncoupling of the SERCA Ca(2+) Pump by Inducing a Structural Rearrangement in the Energy-Transduction Domain, Biochemistry, 55, 6083, 10.1021/acs.biochem.6b00728 · DOI · Paper page
- Sahoo, 2015, The N Terminus of Sarcolipin Plays an Important Role in Uncoupling Sarco-endoplasmic Reticulum Ca2+-ATPase (SERCA) ATP Hydrolysis from Ca2+ Transport, J. Biol. Chem., 290, 14057, 10.1074/jbc.M115.636738 · DOI · Paper page
- Block, 1994, Thermogenesis in muscle, Annu. Rev. Physiol., 56, 535, 10.1146/annurev.ph.56.030194.002535 · DOI · Paper page
- Fu, 2011, Aberrant lipid metabolism disrupts calcium homeostasis causing liver endoplasmic reticulum stress in obesity, Nature, 473, 528, 10.1038/nature09968 · DOI · Paper page
- Fajardo, 2018, Elevated whole muscle phosphatidylcholine: phosphatidylethanolamine ratio coincides with reduced SERCA activity in murine overloaded plantaris muscles, Lipids Health Dis., 17, 47, 10.1186/s12944-018-0687-7 · DOI
- Maurya, 2015, Sarcolipin Is a Key Determinant of the Basal Metabolic Rate, and Its Overexpression Enhances Energy Expenditure and Resistance against Diet-induced Obesity, J. Biol. Chem., 290, 10840, 10.1074/jbc.M115.636878 · DOI · Paper page
- de Meis, 2005, Role of sarco/endoplasmic reticulum Ca(2+)-ATPase in thermogenesis, Biosci. Rep., 25, 181, 10.1007/s10540-005-2884-7 · DOI · Paper page
- Zapata, 2022, Adipocytes control food intake and weight regain via Vacuolar-type H(+) ATPase, Nat. Commun., 13, 5092, 10.1038/s41467-022-32764-5 · DOI
- Perens, 2021, An Optimized Mouse Brain Atlas for Automated Mapping and Quantification of Neuronal Activity Using iDISCO+ and Light Sheet Fluorescence Microscopy, Neuroinformatics, 19, 433, 10.1007/s12021-020-09490-8 · DOI
- Shamsi, 2020, FGF6 and FGF9 regulate UCP1 expression independent of brown adipogenesis, Nat. Commun., 11, 1421, 10.1038/s41467-020-15055-9 · DOI
- Laplante, 2009, Tissue-specific postprandial clearance is the major determinant of PPARgamma-induced triglyceride lowering in the rat, Am. J. Physiol. Regul. Integr. Comp. Physiol., 296, R57, 10.1152/ajpregu.90552.2008 · DOI · Paper page
- Bligh, 1959, A rapid method of total lipid extraction and purification, Can. J. Biochem. Physiol., 37, 911, 10.1139/y59-099 · DOI · Paper page
- Kusminski, 2012, MitoNEET-driven alterations in adipocyte mitochondrial activity reveal a crucial adaptive process that preserves insulin sensitivity in obesity, Nat. Med., 18, 1539, 10.1038/nm.2899 · DOI · Paper page
- Cònsol, 2005, An in situ perfusion protocol of rat epididymal adipose tissue useful in metabolic studies, J. Lipid Res., 46, 1803, 10.1194/jlr.D500016-JLR200 · doi:10.1194/jlr.d500016-jlr200
- Vale, 2019, Three-phase liquid extraction: a simple and fast method for lipidomic workflows, J. Lipid Res., 60, 694, 10.1194/jlr.D090795 · DOI
Cited by
Brain control of energy homeostasis: implications for anti-obesity pharmacotherapy
Johansen, V. B. I., Petersen, J., Lund, J., Mathiesen, C. V., Fenselau, H., & Clemmensen, C. (2025) · Cell · doi:10.1016/j.cell.2025.06.010 · Cited by 53
Wu, H., Yang, W., Guo, T., Cai, X., & Ji, L. (2025) · BMC Medicine · doi:10.1186/s12916-025-04200-0 · Cited by 36
“GLP-1 and GIP receptor agonists seem to have a synergistic effect in weight reduction, although the mechanism is not yet clear [44].”
Novel GLP-1-based Medications for Type 2 Diabetes and Obesity
Son, J. W., le Roux, C. W., Blüher, M., Nauck, M. A., & Lim, S. (2026) · Endocrine Reviews · doi:10.1210/endrev/bnaf036 · Cited by 40
Metadata
- Authors
- Yu, X., Chen, S., Funcke, J.-B., Straub, L. G., Pirro, V., Emont, M. P., Droz, B. A., Collins, K. A., Joung, C., Pearson, M. J., James, C. M., Babu, G. J., Efthymiou, V., Vernon, A., Patti, M. E., An, Y. A., Rosen, E. D., Coghlan, M. P., Samms, R. J., Scherer, P. E., & Kusminski, C. M.
- Venue
- Cell Metabolism
- Publisher
- Elsevier BV
- Published
- 2025-01
- Volume
- 37
- Issue
- 1
- Pages
- 187-204.e7
- ISSN
- 1550-4131 (ISSN-L)
- OpenAlex
- W4405069912
- Cited by
- 67
- References
- 44
- FWCI
- 15.85
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 371 d)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Funders
- Eli Lilly and Company (SRA 201909-0007, SRA 201912-0013)
- Deutsche Forschungsgemeinschaft (444933586, K01-DK125447, RC2-DK116691)
- National Institute on Aging (P01-AG051459-06)
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (R01-DK127274, R01-DK099110, RC2-DK118620, R01-DK55758, R01-DK131537, RC2-DK116691, K01-DK125447, P30-DK127984)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The GIP receptor activates futile calcium cycling in white adipose tissue to increase energy expenditure and drive weight loss in mice. https://app.cochat.ai/papers/10.1016/j.cmet.2024.11.003
- The paper
- Yu, X., Chen, S., Funcke, J.-B., Straub, L. G., Pirro, V., Emont, M. P., Droz, B. A., Collins, K. A., Joung, C., Pearson, M. J., James, C. M., Babu, G. J., Efthymiou, V., Vernon, A., Patti, M. E., An, Y. A., Rosen, E. D., Coghlan, M. P., Samms, R. J., . . . Kusminski, C. M. (2025). The GIP receptor activates futile calcium cycling in white adipose tissue to increase energy expenditure and drive weight loss in mice. Cell Metabolism. https://doi.org/10.1016/j.cmet.2024.11.003
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.